For me, the key message delivered at today's AGM relates to a new anti-obesity project.
Chairman Dr David Brookes says the group aims to develop an "oral medication to assist weight reduction and sustaining weight control in conjunction with other contemporary treatments and approaches."
He says obesity (BMI of 30 kg/m2 or greater) is a medical condition of such prevalence that it is described as a "new pandemic", with associated significant comorbidities and health risk factors.
At a time of already stretched health systems, individuals will need further strategies and treatments to those currently available to manage, control and prevent obesity and rebound weight gain.
"The details of this project remain confidential until such time that we have confirmed Proof of Concept and have security around the know-how and IP involved in the formulations..."
ANR Price at posting:
6.4¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)